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In vitro tracking of IL-7 responsiveness and gene expression
during commitment of bipotent B-cell/macrophage progenitors
Barbara L. Kee and Christopher J. Paige
Background: The development of B lymphocytes from multipotent
hematopoietic stem cells occurs through a series of intermediate cell types with
increasingly restricted developmental potential. Despite intensive investigation,
the underlying basis for commitment to a given lineage or the restriction in
developmental potential of multipotent cells is unknown. To gain insight into this
process we have developed an in vitro system that tracks a bipotent progenitor,
which has the capacity to give rise to both B lymphocytes and macrophages, as
it makes the transition to a B-lineage-committed precursor. The development of
mature B lymphocytes from bipotent progenitors is dependent on interleukin 7
(IL-7), a pre-B-cell growth factor, in addition to other stromal-cell-derived factors
such as IL-11 and mast cell growth factor (MGF). IL-7 acts on pre-B
lymphocytes, but the stage of differentiation at which B-lineage cells become
responsive to this factor, and its potential role in lineage commitment have not
been investigated thoroughly. Here, we examine the requirements for IL-7 during
the development of B lymphocytes from bipotent progenitors. Furthermore, we
define onset of B-lineage-associated gene expression during the development of
committed B-lineage cells under defined culture conditions.
Results: We demonstrate that, under our experimental conditions, bipotent
progenitors commit to differentiation through either the B or macrophage
lineages within the first 3 days of culture. Cells that require IL-7 for survival first
develop on day 3 of culture; however, commitment to the B lineage occurs at the
same frequency in the presence or absence of this factor. After day 3 of culture,
IL-7 is required both for the proliferation and survival of committed B-lineage
progenitors and for the expression of several B-cell-associated genes, such as
l5, VpreB, mb-1 and Rag1.
Conclusions: Our results demonstrate that the growth factor combination of
IL-11 and MGF provides sufficient support for bipotent progenitors to commit to
either the B or the macrophage lineage. Single-cell cloning assays revealed that
IL-7 does not influence the decision to commit to the B lineage, despite the
observation that the bipotent cells potentially respond to IL-7, as indicated by an
increase in cell number, prior to the commitment event. Furthermore, the addition
of IL-7 to cells developing along the B-cell pathway promotes the expression of
mRNA transcripts which encode several B-cell-specific genes.
Introduction
The hematopoietic system consists of distinct cell lineages
which develop from a common multipotent stem cell.
Intermediate cell types arise during the developmental
process which can be recognized by their increasingly
restricted lineage potential. It is likely that both commit-
ment to a lineage and the subsequent progression of com-
mitted cells along a particular developmental pathway is
dependent upon the timely expression of specific genes.
Despite substantial progress in defining cell lineages and
the stages of differentiation within a lineage, the molecular
basis for lineage commitment remains unknown. Attention
has been focused on genes which encode cell-surface
receptors for membrane-associated or soluble factors, pro-
teins which relay signals to the nucleus and transcriptional
regulators which effect gene expression (reviewed in [1,2]).
Analysis of the commitment process itself has been ham-
pered both by the rarity of unrestricted progenitors in
hematopoietic tissues and the absence, until recently, of in
vitro assays which allow the process of commitment to be
observed directly. Consequently, the majority of studies
have focused on the mechanisms which regulate the devel-
opment of mature hematopoietic cells from their lineage-
restricted progenitors [3–5]. We have defined in vitro
culture conditions which allow single, lineage-unrestricted
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hematopoietic progenitors to differentiate through the
entire B-cell developmental pathway, resulting in  plasma
cells secreting immunoglobulin (Ig) [6]. The first identifi-
able progenitor which is able to respond in this assay can
be found in the yolk sac and the para-aortic splanchno-
pleura of murine embryos by the 12-somite stage [7,8].
Such cells express the surface antigen recognized by mon-
oclonal antibody AA4.1 and, under appropriate growth con-
ditions, are able to generate all of the mature elements of
the hematopoietic system [8]. The process of generating
committed B-lineage cells from these multipotent progeni-
tors requires a minimum of one week in vitro, and at least
two weeks are required before Ig+ mitogen-responsive B
cells develop [9].
We have also identified a more restricted progenitor
which, under identical culture conditions, gives rise to B
lymphocytes and macrophages [6]. This bipotent cell is
first detected in the fetal liver at day 12 of gestation and
expresses the surface antigens AA4.1 and Ly6A but does
not yet express B220, the form of CD45 associated with
the B lineage, or the myeloid-associated antigen Mac-1.
Three stromal-cell-derived factors, interleukin 11 (IL-11),
mast cell growth factor (MGF) and IL-7, are sufficient to
support the development of committed B lymphocytes
from these bipotent progenitors [10]. As the transition
from bipotent progenitor to committed B lymphocyte
occurs in a defined culture system, amenable to single cell
analysis, it is an ideal experimental model for tracking
progenitors while they undergo the steps which lead to
lineage commitment.
Cells which have committed to differentiation through the
B lineage can be identified by expression of a unique set of
gene products, many of which play a critical role in B-cell
development [11]. For example, a surrogate light chain
complex composed of l5 and VpreB, which can associate
with m heavy chain, is expressed exclusively in B-cell prog-
enitors [12,13]. B29 and mb-1 are expressed at all stages of
B-cell development and function to mediate signals deliv-
ered through Ig [14,15]. It remains to be determined
whether these proteins are expressed at an appropriate
time to function in lineage determination; however, mice
harboring null mutations in a number of these genes
nonetheless develop apparently committed B-lineage
progenitors [16–18]. This observation suggests that, indi-
vidually, these proteins are not required for B-lineage com-
mitment but does not, of course, exclude a role for these
proteins under conditions where they can be expressed [2].
In addition to the expression of unique genes, distinct lin-
eages can be identified by their differential responses to
growth factors or cytokines. The function of these factors in
the commitment process has not been resolved and models
ranging from inductive to stochastic have been proposed
(reviewed in [19]). Elucidation of the precise function of
growth factors is complicated by the fact that they play a
concomitant role in cell survival. That is, in the absence of
a required factor progenitors die by a process of apoptosis,
whereas in their presence selection for responsive progen-
itors is inevitable. A number of factors have been found
that influence the growth of committed B-lineage cells
and foremost among these is interleukin 7 (IL-7) [20].
The dramatic reduction in the numbers of B-cell progeni-
tors observed in mice treated with neutralizing antibodies
directed against IL-7 or the IL-7 receptor [21,22], and in
mice deficient in IL-7 receptor [23], demonstrates the crit-
ical role of this factor in B-cell development. However, the
early developmental stage at which this reduction is
observed raises the possibility that IL-7 may be required
for, or promote, commitment to the B lineage. Recent
studies by Whetton and colleagues have suggested that
growth factors can influence commitment and the choice
of lineage of bipotent granulocyte/macrophage progenitors
[24]. Specifically, factors which cause the nuclear translo-
cation of protein kinase C-a (such as M-CSF (macrophage
colony stimulating factor) and IL-4) favor commitment to
macrophage development [24,25].
We have investigated the ability of IL-7 to influence com-
mitment of bipotent B-cell/macrophage progenitors and its
role in the subsequent progression of progenitors through
the B-lineage developmental pathway. We find that,
although IL-7 is necessary for progression it is not required
for, nor does it influence, commitment to the B lineage.
Remarkably, expansion of bipotent cells appears to occur
in response to IL-7 prior to lineage restriction and prior to
the stage of differentiation which requires this factor for
survival. These results suggest a state of commitment-
neutral responsiveness to a cytokine which subsequently is
required for the survival and expansion of committed
B-lineage cells. IL-7 is necessary to allow B-lineage-
restricted progenitors to express the lineage-associated
genes l5, VpreB, mb-1, Rag-1 and BP-1/6C3, indicating
that these genes are not involved in the commitment
process. Surprisingly, mRNA transcripts encoding B29 and
IL-7Ra are expressed at similar levels in the presence or
absence of IL-7, indicating that their regulation is distinct
from other B-lineage-associated genes. Our data define a
novel IL-7-dependent transitional stage during B-cell
differentiation, after commitment, but prior to the expres-
sion of lineage-restricted markers of B-cell development.
Results
Bipotent B-cell/macrophage precursors require IL-11 and
MGF, but not IL-7, at the initiation of culture
The combination of the factors IL-11, MGF and IL-7 is
sufficient to support the development, in vitro, of pre-B
lymphocytes and macrophages from single AA4.1+ B220–
Mac-1– Ly6A+ cells isolated from murine fetal liver at day
12 of gestation [10]. In order to assess the requirement for
IL-11, MGF and IL-7 during B-cell development from
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bipotent progenitors, we performed a series of experiments
in which the addition of one or more of these factors to the
culture medium was delayed. All cultures were maintained
for 10 days at which time pre-B-cell development was
assessed by measuring the production of IgM after transfer
of the cells to a second culture containing a stromal cell
line and the B-cell mitogen lipopolysaccharide (LPS) [26].
The initial 10-day culture period was chosen because pre-
vious experiments have shown that a minimum of 8 days is
required for the development of pre-B lymphocytes from
bipotent progenitors [10,27].
As expected, bipotent precursors cultured in medium con-
taining IL-11, MGF and IL-7 for 10 days gave rise to pre-B
lymphocytes which were able to respond in the mitogen
assay (Fig. 1, zero time points). In contrast, pre-B lympho-
cytes did not develop in cultures to which IL-11 and MGF
was added after 24 or more hours (Fig. 1a). In fact, delaying
the addition of IL-11 and MGF for even 12 hours resulted
in a 1000-fold reduction in the total number of cells, sug-
gesting that the majority of progenitors do not survive in
the absence of IL-11 and MGF (data not shown). These
observations are consistent with our previous experiments
which demonstrated that IL-7 alone is insufficient for the
development of B-lineage cells from bipotent precursors
[10,27]. Delaying the addition of MGF, or MGF and IL-7,
for 24 hours to cultures containing IL-11 and IL-7, or IL-11
only, also had a significant effect on the development of
pre-B lymphocytes (Fig. 1b,c, respectively).
In contrast, mitogen-responsive B lymphocytes did develop
in cultures to which the addition of IL-7 had been delayed
for several days (Fig. 1d). The precise length of time the B-
cell progenitors survived in the absence of IL-7 varied in
independent experiments, but was generally 5–6 days. In
every experiment IL-7 was eventually required for the
development of pre-B lymphocytes as no IgM-secreting
cells were detected in this assay if the addition of IL-7 was
delayed for more than 6 days (Fig. 1d) [10,27].
Identification of an IL-7-independent stage in the
development of B lymphocytes from bipotent progenitors
The data presented in Figure 1 raise the possibility that IL-
11 and MGF are sufficient to support the survival of bipo-
tent progenitors. In order to determine the number of
progenitors which could survive in the absence of IL-7, and
the kinetics of IL-7 dependency, the progenitors were
plated, at the initiation of culture, under limiting-dilution
conditions in IL-11 and MGF, and the addition of IL-7 was
delayed (for 0–6.5 days). The development of B-lineage
cells was assessed on day 10 of culture by transferring the
progeny to the mitogen assay. Figure 2a demonstrates that
the majority of progenitors (>95 %), present at the initiation
of culture, survived for 2–3 days in the absence of IL-7.
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Figure 1
The development of mitogen-responsive B
cells from bipotent progenitors requires IL-11
and MGF, but not IL-7, at the initiation of
culture. AA4.1+ B220– Mac-1– Ly6A+
progenitors were isolated from fetal livers at
day 12 of gestation as described in Materials
and methods. The enriched cells were
cultured (1 × 103 cells per well in a 24-well
dish) in the presence of IL-7 (a), IL-11 and
IL-7 (b), IL-11 (c) or IL-11 and MGF (d). On
days 0–10 of culture, as indicated on the x
axis, the remaining factors were added to
independent wells. On day 10 the cells
present in each well were resuspended in
2 ml of media and a 50 ml aliquot was
transferred to the mitogen assay, containing
S17 and LPS (five replicates per well) to test
for the development of B-lineage cells that are
competent to secrete IgM under these
conditions. The concentration of IgM in the
culture supernatant, y-axis, was determined by
enzyme-liked immunosorbant assay (ELISA)
on day 25 of culture. Under the conditions of
this assay the concentration of IgM produced
can not be directly correlated to the number
of B-lineage cells present at the time of
transfer to the mitogen assay. One of four
independent experiments is shown.
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The precise length of time varied in independent experi-
ments from 2 to 4 days (data not shown). After this time a
steady decline in the number of clonable progenitors was
observed. However, as many as 10 % of the progenitors
survived for 6 days in the absence of IL-7 (Fig. 2a). 
The period prior to IL-7 dependence reflects either the
time required for the development of IL-7-dependent
cells or the survival period of IL-7-dependent cells after
IL-7 withdrawal. Previous studies using factor-dependent
cell lines have demonstrated that withdrawal of a required
growth factor leads to cell death within 24 hours [28,29].
Figure 2b shows that this is also true for primary, IL-7-
expanded, pre-B lymphocytes. In this experiment B220+
cells were isolated from fetal liver at day 14 of gestation
and cultured in IL-7 for 3 days. At that time the cells were
replated under limiting-dilution conditions in media
lacking IL-7. IL-7 was added after the indicated time and
the presence of B-lineage cells was assessed on day 8 in
the mitogen assay. It is apparent from Figure 2b that with-
drawal of IL-7 leads to a rapid loss in the capacity of these
cells to develop into B lymphoyctes. Taken together, our
data suggest that the bipotent cells pass through an IL-7-
independent phase which results in the appearance of
B-cell progenitors which require IL-7 for survival.
IL-7 is required for expansion of clonable B-cell
progenitors
We next examined more precisely the time of emergence
of the first cells which proliferate in response to IL-7. The
data in Figure 3 show that, in the presence of IL-11, MGF
and IL-7, the absolute number of B-cell progenitors did
not increase over the first 48 hours. Numbers of clonable B
cells did, however, increase after 2–4 days of culture, con-
comitant with the requirement for IL-7 by some progeni-
tors (Fig. 3). This increase in cell number was seen only
when IL-7 was present in the culture medium (Fig. 3).
Although numbers of B-cell progenitors did not increase
during the first 48 hours of culture, we did observe a 10-
fold increase in the total number of cells (Fig. 3). This
increase in cell number was not dependent on IL-7 and
can be attributed, in part, to the presence of myeloid prog-
enitors which proliferate in the presence of IL-11 and
MGF. As the numbers of B-cell progenitors are not
increasing during this period, the frequency of these cells
declines. In order to enrich for the B-lineage progenitors
we examined the expression of a number of cell-surface
proteins known to be expressed at the early stages of B-
cell development (Fig. 4). Neither B220 nor BP-1/6C3
were expressed at detectable levels prior to day 6 of
culture. The myeloid-associated antigen Mac-1 was
expressed by approximately 45 % of progenitors by day 4
of culture, by 80 % by day 6; then expression began to
decline. This decline in Mac-1+ cells is attributed partially
to the expansion of B-lineage cells; however, the doubling
time of the macrophage progenitors also declines after day
6 of culture in the absence of M-CSF (unpublished obser-
vations). At the time of isolation more than 80 % of
selected cells expressed Ly6A and all of the bipotent
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Figure 2
Survival of bipotent progenitors and their
progeny in the absence of IL-7. (a)
AA4.1+ B220– Mac-1– Ly6A+ progenitors were
isolated from fetal livers at day 12 of gestation
and cultured under limiting-dilution conditions
in the presence of IL-11 and MGF (270, 90,
30, 10 and 3.3 cells per well; 48 wells per cell
concentration). IL-7 was added to each series
of limiting-dilution plates 0, 1, 2, 4.6, 5.6 and
6.5 days after the initiation of culture. On day
10 of culture, 25 % of the cells present in each
well were transferred to the mitogen assay, to
test for the development of pre-B lymphocytes.
The presence of IgM in the culture supernatant
was determined on day 25 of culture by
ELISA. The number of responding progenitors
per fetal liver was calculated from the
frequency of IgM-producing cells, the fraction
of fetal liver cells with the selected phenotype
and the total number of cells per fetal liver.
One of three independent experiments is
shown. (b) B220+ cells were isolated from
fetal livers at day 14 of gestation and cultured
in the presence of IL-7 for 3 days (5 × 104 cells
per well in a 24-well dish). The resulting IL-7-
dependent pre-B cells were washed three
times in PBS and replated under limiting-
dilution conditions in the absence of IL-7 (810,
270, 90, 30, 10 and 3.3 cells per well; 48
wells per cell concentration). IL-7 was added
to a series of limiting-dilution plates 0, 0.5, 1, 2
and 3 days after the initiation of culture. On
day 8 of culture, 25 % of the cells present in
each well were transferred to the mitogen
assay. The presence of IgM in the culture
supernatant was determined  by ELISA on day
23 of culture. The number of responding
progenitors was calculated from the proportion
of IgM-producing cells and the total number of
cells present in the IL-7-dependent cultures
used to initiate the limiting-dilution assay. One
of two independent experiments is shown.
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progenitors are found within this population [6]; however,
only a small percentage of cells (5–20 %) expressed this
antigen between 4 and 6 days after the initiation of
culture. We hypothesized that this marker might be useful
for re-enrichment of B-lineage progenitors during the
culture period.
In order to test this hypothesis we isolated the Ly6A+ and
Ly6A– cells from cultures containing IL-11, MGF and
IL-7 on days 2, 3 or 4 and determined the frequency of
clonable B-cell progenitors in each population. Table 1
demonstrates that the frequency of B-cell progenitors was
enriched in the Ly6A+ fraction, whereas the Ly6A– frac-
tion did not contain detectable numbers of B-cell progeni-
tors. We also examined the utility of Ly6A as a marker for
enrichment of B-cell progenitors from cultures containing
IL-11 and MGF. In the absence of IL-7, Ly6A+ cells
declined from 25 % on day 2 to 5–10 % on day 4 of culture
(Fig. 4b and Table 1). This decline was slightly greater
than that observed in the presence of IL-7, consistent
with the lower number of B-cell progenitors present under
these culture conditions. As noted for the culture contain-
ing IL-11, MGF and IL-7, essentially all of the B-cell
progenitors in the culture containing IL-11 and MGF
were present in the Ly6A+ population (Table 1).
B-lineage commitment does not require IL-7
The requirement for IL-7 by some progenitors between
days 2 and 6 of culture may reflect the gradual emergence
of B-lineage-restricted progenitors which subsequently
require IL-7 for survival. Alternatively, IL-7 may be
required for commitment of bipotent B-cell/macrophage
precursors to the B lineage. We have shown that, under
our culture conditions, IL-7 is required for both the sur-
vival and expansion of the progeny of bipotent precursors;
however, the developmental potential of the first IL-7-
requiring cells is not known. In order to examine the
requirement for IL-7 in the development of B-lineage-
restricted cells we determined the developmental poten-
tial of individual progeny of B-cell/macrophage precursors
after culture in IL-11 and MGF with or without IL-7 for
3 days (Fig. 5, Table 2). The data in Table 2 show that
approximately 75 % of the AA4.1+ B220– Mac-1– Ly6A+
B-cell progenitors, isolated from day-12 fetal liver, give rise
to both pre-B lymphocytes and macrophages when cul-
tured in IL-11, MGF and IL-7, consistent with our previ-
ous estimates [10]. In contrast, single cells isolated 3 days
after the initiation of culture in IL-11, MGF and IL-7 gave
rise to B lymphocytes or macrophages only. None of the
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Figure 3
IL-7 is required for the expansion of clonable B-cell progenitors.
AA4.1+ B220– Mac-1– Ly6A+ progenitors were isolated from fetal livers
at day 12 of gestation and cultured in IL-11 and MGF with (squares) or
without (circles) IL-7 (5 × 103 cells per well in a 24-well dish). On the
indicated day of culture one well was harvested, the total number of
cells counted (open circles and squares), and the progenitors
transferred to limiting-dilution conditions in the presence of IL-11, MGF
and IL-7 to quantitate the number of B-cell progenitors (filled circles
and squares) present in the culture. On day 10 of culture, 25 % of the
cells present in each well were transferred to the mitogen assay. The
number of clonable B-cell progenitors was determined from the
frequency of progenitors and the total number of cells present in the
culture at the time that the limiting-dilution assay was established.
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Table 1
Frequency of clonable B-cell progenitors in the Ly6A+ and
Ly6A– fractions after in vitro culture in the presence or absence
of IL-7.
Frequency of clonable
B-cell progenitors
Experiment Day of culture IL-7 % Ly6A+ Ly6A+ Ly6A–
A 2 + 38 % 1:120 nd
B 2 + 34 % 1:10 nd
– 25 % 1:20 nd
C 3 + 15 % 1:110 <1:1200
D 3 + 40 % 1:120 <1:1200
E 4 + 20 % 1:40 <1:1200
– 11 % 1:140 <1:1200
F 4 + 10 % 1:82 <1:3000
– 5 % 1:80 <1:3000
G 4 + 7 % 1:15 <1:3000
– 4 % 1:27 <1:3000
AA4.1+ B220– Mac-1– Ly6A+ progenitors were isolated from fetal livers
at day 12 of gestation and cultured in IL-11, MGF and IL-7, or IL-11 and
MGF (1 × 103 cells per well in a 24-well dish). On the indicated day
after the initiation of culture, the cells were harvested and stained with
anti-Ly6A-PE. The Ly6A+ and Ly6A– fractions were sorted on a
FACStar Plus. The Ly6A+ and Ly6A– populations were cultured under
limiting-dilution conditions in the presence of IL-11, MGF and IL-7 to
determine the frequency of clonable B-cell progenitors in each
population. On day 10 of culture 25 % of the cells present in each well
were transferred to the mitogen assay and the concentration of IgM
secreted into the supernatant was determined by ELISA on day 25 of
culture. The frequency of clonable B-cell progenitors was determined as
described in Materials and methods; nd, not determined.
wells containing B lymphocytes contained macrophages.
Similarly, single cells isolated 3 days after the initiation of
culture in IL-11 and MGF gave rise to B lymphocytes or
macrophages only. Remarkably, the frequency of commit-
ted B-lineage cells in the Ly6A+ population was similar in
the presence or absence of IL-7 (18 % versus 14 % and
18 % versus 17 % in experiments B and C, respectively).
Taken together, the data demonstrate that commitment of
bipotent progenitors to the B lineage is not dependent on,
or influenced by, the presence of IL-7, and that lineage
restriction occurs within 3 days after the initiation of
culture.
The requirement for IL-7 defines a novel transition at the
early stages of B-cell development
To further define the requirement for IL-7 in B-cell
development in vitro we examined the expression of B-
lineage-associated genes in the Ly6A+ population arising
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Figure 4
Expression of lineage-associated antigens
during in vitro culture of bipotent progenitors.
(a) AA4.1+ B220– Mac-1– Ly6A+ progenitors
were isolated from fetal livers at day 12 of
gestation and cultured (1 × 103 cells per well
in a 24-well dish) in IL-11, MGF and IL-7. At
the indicated time after the initiation of culture
0.5–1 × 104 cells were harvested and
examined for expression of Mac-1, B220, BP-
1/6C3 or Ly6A by FACS analysis as
described in Materials and methods. The
percentages of cells expressing the indicated
antigens are shown. (b) The bipotent
population was cultured (1 × 103 cells per well
in a 24-well dish) in IL-11, MGF and IL-7 or
IL-11 and MGF, as indicated. On day 4 of
culture, the cells were harvested and stained
with anti-Ly6A (black), or control IgG2b (gray)
antibodies conjugated to phycoerythrin, and
the relative fluorescence intensity was
analyzed on a FACStar Plus. Forward light
scatter (FSC) versus side light scatter (SSC)
is shown for each sample. Histograms are
shown with the relative cell number on the y
axis and the relative fluorescence intensity on
the x axis.
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after culture of bipotent progenitors in IL-11 and MGF in
the presence or absence of IL-7 (Fig. 6). In preliminary
experiments we detected mRNA corresponding to B29 in
the AA4.1+ B220– Mac-1– Ly6A+ population at the time of
isolation, whereas mRNAs corresponding to BP-1/6C3,
mb1, Rag-1, l5, VpreB were not detected (data not
shown). In cultures containing IL-11, MGF and IL-7,
expression of these genes was first detected between 3
and 4 days after the initiation of culture (Fig. 6b). By con-
trast, bipotent precursors cultured for 3 or 4 days in IL-11
and MGF in the absence of IL-7 expressed 100-fold lower
levels of mRNA corresponding to BP-1/6C3, mb-1, Rag-1,
l5 and VpreB than the same bipotent population cultured
in IL11, MGF and IL-7 (Fig. 6b). 
These differences in gene expression do not reflect dif-
ferences in the relative numbers of B-cell progenitors
present in the expanded populations, as the progenitors
were selected for Ly6A. The frequency of clonable B-cell
progenitors in either Ly6A+ population on day 3 of
culture was similar and by day 4 of culture there were
only 3-fold more B-cell progenitors in the Ly6A+ popula-
tion isolated from cultures containing IL-7. Furthermore,
mRNA corresponding to the IL-7Ra and B29 were
detected at equivalent levels in either population, indi-
cating that sufficient numbers of B-lineage progenitors
were present in each population to allow detection of
these genes (Fig. 6b). As B-lineage commitment from
bipotent progenitors is not dependent on IL-7, our data
indicate that the expression of many B-lineage-associated
genes is not required for the commitment process. Fur-
thermore, the data suggest that IL-7 is required by B-
lineage progenitors after lineage commitment and after
Research Paper  IL-7 in B-lineage commitment Kee and Paige    1165
Figure 5
Flow diagram of protocol used to generate data in Table 2. A, B and C
refer to corresponding experiments listed in Table 2.
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Table 2
B-lineage commitment occurs by day 3 of culture in the presence or absence of IL-7.
Number of clones containing
Experiment Day of IL-7 % Ly6A+ Clonable cells/cells B cells B cells macrophages B cells and 
cloning plated (fraction) (fraction) only only macrophages
A 0 + 100 70/384 (0.18) 20 (0.29) 5 10 15
B 3 + 20 148/480 (0.31) 27 (0.18) 27 97 0
– 12 115/360 (0.32) 16 (0.14) 16 69 0
C 3 + 27 98/384 (0.25) 18 (0.18) 18 63 0
– 13 104/384 (0.27) 18 (0.17) 18 71 0
AA4.1+ B220– Mac-1– Ly6A+ progenitors were isolated from fetal
livers at day 12 of gestation as described in Materials and methods. In
experiment A, single progenitors were deposited directly into each well
of a 96-well dish containing 250 ml of IL-11, MGF and IL-7.
Alternatively, in experiments B and C, the progenitors were plated at a
low cell density in IL-11 and MGF in the presence or absence of IL-7
(1 × 103 cells per well in a 24-well dish). On day 3 of culture, the cells
were harvested and stained with anti-Ly6A-PE. Single Ly6A+ cells
were deposited into each well of a 96-well plate containing 250 ml of
IL-11, MGF and IL-7. On day 7 of culture recombinant M-CSF was
added to all cultures. The presence of B-cell progenitors was
confirmed by transferring the non-adherent cells to the mitogen assay,
containing S17 and LPS, on day 10 of culture. On day 25 of culture,
the presence of IgM in the culture supernatant was determined by
ELISA. The development of macrophages was confirmed by the
presence of adherent cells which proliferate in response to M-CSF and
by morphology on cytospin preparations stained with leukostat. The
number of clonable cells which developed into B cells, macrophages,
or B cells and macrophages is reported.
the onset of expression of B29 and IL-7Ra, but prior to
expression of many B-lineage-associated genes.
Discussion
IL-7 is a potent proliferative stimulus for pre-B lympho-
cytes, and responsiveness to this factor is one of the earliest
events in B-cell development. These observations raised
the possibility that IL-7 may initiate a signaling pathway in
lineage-unrestricted progenitors, which favors commitment
to the B lineage. The data presented in this manuscript,
however, demonstrate that IL-7 is required for the expan-
sion of B-cell progenitors in vitro but it is not required for
the development of B-lineage-restricted cells from bipotent
progenitors. Furthermore, the presence of IL-7 did not
influence the frequency of progenitors which commit to
the B lineage. These results suggest that two pleiotropic
factors, IL-11 and MGF, are sufficient to support B-lineage
commitment from bipotent progenitors, and that IL-7 or an
alternative specific factor is not required.
Remarkably, IL-7 may have an effect on B-cell progenitors
prior to definitive lineage restriction. We observed a two-
fold increase in the percentage of Ly6A+ cells in cultures
containing IL-7 compared with those that did not contain
IL-7, yet the fraction of committed B-cell progenitors in
the Ly6A+ population was similar under either culture con-
dition (see Table 2). This result is not consistent with a
model in which bipotent progenitors merely undergo com-
mitment to the B lineage and subsequently respond, by
proliferation, to IL-7. Such a model would predict that the
proportion of B-cell progenitors in the Ly6A+ population
should be greater in cultures containing IL-7. That the
proportion of B-cell progenitors is similar under either
culture condition suggests that a response to IL-7 occurred
prior to the commitment event. Alternatively, non-B-
lineage cells within the Ly6A+ population may be able to
respond to IL-7 by proliferation. However, we do not favor
this second hypothesis because the proportion of B-cell
progenitors in the Ly6A+ population does increase after
day 3 of culture in the presence of IL-7. This observation
suggests that the other cells present in this population do
not have a sustained response to this factor. However,
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Figure 6
IL-7 is required for the optimal expression of many B-lineage-
associated genes. AA4.1+ B220– Mac-1– Ly6A+ cells were isolated
from fetal livers at day 12 of gestation and cultured (1 × 102 cells per
well in a 24-well dish) in IL-11 and MGF with (+ IL-7) or without (– IL-7)
IL-7, as indicated at the top of (a) and the top of (b). On day 3 (D3) or
4 (D4) of culture the cells were harvested, stained with anti-Ly6A-PE
and the Ly6A+ cells were selected on a FACStar Plus. A portion of the
Ly6A+ cells were plated under limiting-dilution conditions in IL-11,
MGF and IL-7 to quantitate the number of B-cell progenitors. The
remaining cells were amplified (in duplicate) by the Poly A+ PCR
procedure, as described in Materials and methods. Two independent
amplifications are shown. The mRNA from the A-MuLV pre-B-cell line
CB17 5.1 and the stromal cell line S17 was amplified under identical
conditions. Specific PCR primers were used to detect the amplified
products corresponding to the B-lineage-associated genes BP-1/6C3,
mb-1, Rag-1, l5, VpreB, B29 and IL-7Ra and the ribosomal protein
L32, as indicated on the right side of the figure. The amplified products
were detected using a radiolabeled probe containing sequences within
the terminal 500 bp of each mRNA as described previously [6]. The
D3 and D4 samples are from independent experiments.
(b)
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further investigation is required to determine the effects of
IL-7 on bipotent progenitors. The possibility that the bipo-
tent progenitors proliferate in response to IL-7 is sup-
ported by the development of leukemias containing both
pre-B lymphocytes and macrophages in transgenic mice
that overexpress IL-7 [30].
The data presented in Table 2 show that 75 % of the B-cell
progenitors isolated in the AA4+ B220– Mac-1– Ly6A+ pop-
ulation of day-12 fetal liver also are macrophage progeni-
tors. However, 25 % of the B-cell progenitors gave rise
exclusively to B cells. We consider it unlikely that the
progenitors which only gave rise to B cells are mature ‘con-
taminants’ in this population because: cells that respond to
IL-7 alone are undetectable in this population (frequency
<1 in 3000) [10]; and, in the experiments depicted here, we
failed to find evidence for either expansion in the presence
of IL-7 or death in the absence of IL-7, during the first 48
hours — properties that would be associated with more
mature progenitors present at the initiation of culture. It
may be that these progenitors are, in fact, bipotent but
gave rise to progeny all of which committed to the B
lineage. Although this is unlikely if the decision to commit
is delayed by several cell divisions, it is quite probable if
the decision to commit occurs after the first cell division.
Previous studies have suggested that IL-7 is required for
the expression of BP-1/6C3 on B-cell progenitors [31] and
for expression of Rag-1 and Rag-2 during T-cell develop-
ment [32,33]. It was not determined, however, whether
IL-7 induced gene expression directly or, alternatively,
whether IL-7 was needed to promote or allow cells to
survive and reach a stage of differentiation characterized
by the expression of these genes. Indeed, we have shown
that clonable B-cell progenitors do not survive for longer
than 24 hours after withdrawal of IL-7. We investigated
the requirement for IL-7 in the expression of several B-
lineage-associated genes under conditions in which the
frequency, absolute number and factor-responsiveness of
the B-lineage progenitors was established. Under the con-
ditions of our assay the first IL-7-responsive cells are
apparent within 2–3 days and precede the appearance of
BP1/6C3+ cells by several days, suggesting that IL-7 does
not induce the expression of BP1/6C3 immediately. The
presence of IL-7 does lead to an increase in mRNA encod-
ing l5, VpreB, mb-1 and Rag-1, reflecting either cell loss
in the absence of IL-7, or regulation of expression by IL-7.
Remarkably, expression of B29 was not dependent on the
presence of IL-7, indicating that B29, and IL-7Ra, are
regulated in a manner distinct from that of the remaining
B-lineage-associated genes.
Our results are consistent with the arrest in B-cell-devel-
opment observed in mice treated with a neutralizing anti-
body directed against IL-7/IL-7R and in IL-7Ra-deficient
mice [21,23,34]. In all of these mice, B-cell development
is perturbed at a stage prior to the expression of BP-1/6C3.
Normal numbers of B220+ CD43+ HSAlo progenitors are
present; however, the developmental potential of this
population has not been determined [11,35]. Our results
provide the first demonstration that IL-7 does not influ-
ence commitment to the B lineage. The fact that some
mature B cells do develop in IL-7Ra-deficient mice sug-
gests that IL-7 is not an obligatory requirement for B-cell
development. This result would be predicted if the role of
IL-7 is to promote survival and growth, rather than to
induce differentiation directly. After sufficient numbers of
progenitors have been generated, a few may, by chance,
survive long enough for all of the necessary differentiative
events to occur, resulting in the development of a mature
B cell. Given the limited number of progenitors examined
in our in vitro assay it is not surprising that such an event
would not be detected.
The phenotype of B-lineage progenitors cultured in the
absence of IL-7 is similar to that observed in E2A- and Pax-
5-deficient mice and in transgenic mice expressing Id, an
inhibitor of helix–loop–helix transcription factors, in the B
lineage [36–38]. These mice have a reduced number of
B220+ cells and demonstrate an arrest in B-cell develop-
ment at an immature stage, prior to expression of BP-1/6C3.
Furthermore, the progenitors which are present expressed
B29 but a number of other B-lineage-associated genes were
not detected. It is unlikely that all of these genes are regu-
lated by E2A or Pax-5 directly, suggesting that a unique
gene, or set of genes, may be regulated by these factors.
Taken together, these results indicate that E2A, Pax-5 and
IL-7 may be required for progression through the earliest
stages of B-cell development. E2A and Pax-5 may function
downstream of the IL-7R signaling pathway; alternatively,
they may function in a pathway which is required, in
addition to IL-7, at this stage of development.
Conclusions
The biochemical and genetic basis for restriction of
pluripotential progenitors to differentiation through a
single lineage remains an important issue in biology. The
Research Paper  IL-7 in B-lineage commitment Kee and Paige    1167
Figure 7
Diagram depicting key events in the differentiation of B-lineage cells
from bipotent progenitors. M, macrophage; B, B cell.
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precise role of growth and/or differentiation factors in this
process can be particularly difficult to assess because of
the fundamental link between the survival of a cell and
the ability of genes within that cell to be expressed. We
have developed a defined experimental system with
which a critical step of commitment can be tracked care-
fully. We have used this system to determine the role of a
growth factor which is required for completion of the B-
cell developmental pathway. Progenitor cells which have
the capacity to differentiate into either the B-cell or the
macrophage lineage are highly enriched in the AA4+
B220– Mac-1– Ly6a+ fraction of day-12 fetal liver. These
cells, which require IL-11 and MGF when placed in vitro,
give rise after several days to precursors which are
restricted in their developmental potential to the B
lineage and require IL-7 for survival and expansion. Sur-
prisingly, we found that addition of IL-7 may influence
the cells developing in this culture system prior to the
appearance of cells which require IL-7 for survival. Single
cell subcloning experiments revealed that the commit-
ment process itself was not influenced by the presence of
IL-7; however, subsequent progression along the B-cell
developmental pathway did require IL-7 (Fig. 7).
Materials and methods
Mice
C57BL/6 and BALB/c mice were purchased from Jackson Laborato-
ries (Bar Harbor, Maine) and housed at the animal colony of the
Ontario Cancer Institute. Timed pregnancies were established as
described previously [28].
Culture conditions 
Cell lines and primary cells were maintained in OptiMEM (Gibco) sup-
plemented with 5 × 10–5 M 2-mercaptoethanol and 2 % or 10 % FCS,
respectively. Conditioned medium from an NIH-3T3 cell line trans-
fected with an IL-7 expression vector was used at a 1 in 100 dilution as
a source of IL-7 (provided by F. Melchers, Basel Institute for Immunol-
ogy). Purified recombinant IL-7 was used at a concentration of
250 U ml–1 (provided by S. Gillis, Immunex Corp.), recombinant murine
MGF was used at 100 ng ml–1 (provided by S. Gillis, Immunex Corp.),
recombinant IL-11 at 100 ng ml–1 (provided by D. Donaldson, Genetics
Institute), M-CSF at 10 ng ml–1 (Genzyme) and lipopolysaccharide
(LPS) was used at a concentration of 10 mg ml–1 (Gibco).
Isolation of bipotent B-cell/macrophage progenitors
AA4.1+ B220– Mac-1– Ly6A+ cells were isolated from day 12 of gesta-
tion fetal liver by panning on antibody-coated petri dishes as previously
described [10]. 
Limiting-dilution analysis
Limiting-dilution cultures were established in flat bottom 96-well plates
(Falcon 3072) containing the indicated growth factor combinations, or
an adherent layer of stromal cells (1000 cells per well), which were irra-
diated before use (2000 rad) using a Cs137 source [27]. Cells were
plated at a minimum of three cell concentrations (200 µl per well; 32 or
48 wells per cell concentration) for the indicated length of time, after
which approximately 25 % of each culture was transferred to the
mitogen assay containing an irradiated layer of stromal cells and LPS.
The cultures containing stromal cells plus LPS were maintained,
without replacement of the medium, until day 25, when the concentra-
tion of Ig in the culture supernatant was determined by ELISA, as
described previously [10]. The fraction of wells which were negative for
Ig production was plotted against the number of input cells per well
and a least squares regression line fit to the data. The frequency of B-
cell progenitors was determined as the number of input cells per well,
where 37 % of the wells were non-responding (negative for Ig produc-
tion) [39]. The absolute number of B-cell progenitors was calculated
from the frequency of responding B-cell progenitors and the number of
cells in the input population.
Fluorescence analysis and cell sorting
For FACS analysis 1–5 × 105 cells were stained with the indicated anti-
bodies as described previously [27]. The fluorescence intensity was
measured on a FACScan (Becton Dickenson) and analyzed using the
Lysis II software system. For cell sorting, the indicated cell population
was isolated and incubated with anti-Ly6A conjugated to phycoerythrin
as for FACS analysis. The Ly6A+ and Ly6A– cells were sorted, on a
FACStar Plus (Becton Dickenson), into 4 ml of medium containing the
indicated growth factors. The recovered cells were plated under limit-
ing-dilution conditions, or analyzed by PCR as described below. Alter-
natively, the automatic cell deposition unit (ACDU) on the FACStar
Plus was used to sort single cells directly into individual wells of a 96-
well plate containing 250 ml of medium supplemented with IL-11, MGF
and IL-7. Of 576 wells examined, only one well was found to have more
than one cell.
PolyA+ PCR 
The polyA+ PCR procedure was performed as described by Brady et al.
[40,41]. For each amplification 2000 cells were lysed in 100 ml of PCR
lysis buffer (50 mM Tris–Cl (pH 8.3), containing 75 mM KCl, 3 mM
MgCl2 and 0.5 % NP-40) with the addition of 4 units of RNAguard
(Pharmacia), 250 mM dNTPs and 1 ODU ml–1 oligo dT20 (Amgen or
GST). A 20 ml aliquot (200 cell equivalents) was used to create the first
strand of cDNA, and processed according to Brady et al. [40]. The
PCR amplification contained 8 ml of tailed cDNA (80 cell equivalents)
and was amplified for 25 cycles of 1 min at 94 oC, 1 min at 42 oC and
6 min at 72 oC, followed by 25 cycles of 1 min at 94 oC, 1 min at 42 oC
and 2 min at 72 oC. The sequence of the pGdT primer is
5′–ATGTCGTCCAGGCCGCTCTGGACAAAATATGAATTC (T)24–3′.
The presence of amplified mRNA corresponding to B lineage-associ-
ated genes was detected using specific PCR primers. The global 3′
PCR products were diluted 50-fold in distilled water and 1 ml of the
diluted sample was amplified. The samples were amplified in a 100 ml
volume containing 1× Taq polymerase buffer, 250 mM dNTP, 0.5 pmole
5′ primer, 0.5 pmole 3′ primer, and 5 units of Taq polymerase. Each
sample was amplified through 20 cycles of 1 min at 94 oC, 1 min at
58 oC and 2 min at 72 oC. The 5′ and 3′ primers used in this study are
as follows: for B29, 5′–GCTACTTGACAAGGATGACGG–3′,
5′–CCATGGTCCTCCTAGACTCC–3′; mb-1, 5′–GCAGAAGGGAT-
CATCTTGC–3′, 5′–CGAGGATGCTAATCAG–3′; VpreB, 5′–GCATT-
TACAGCATTTACTGG–3′, 5′–CCAGACTAGCCGAGCAAAGC–3′;
l5: 5′–CCAGGTGCTCGTTTTATAGG–3′, 5′–GCAGGTGAC-
ACACTCTTCTCC–3′; Rag-1, 5′–GACATATGTGTGCCCACC–3′,
5′–AGTAGAGCTCGTGGAAAGCC–3′; BP-1/6C3, 5′–GGTTCGC-
TAGCCTGCCGTAGGACG–3′, 5′–GGCAATACACCCTGCAAG-
TACTGG–3′; IL-7Ra, 5′–GGGTGTGGCATACCAATGAC–3′,
5′–GGACTCACATAGGAGGAC–3′; L32, 5′–GCACTGCCTACGAG-
GTGGCTACC–3′, 5′–GGTGACTCTGATGGCCAGCTGTGC–3′.
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